← Back to Clinical Trials
Recruiting NCT07629141

NCT07629141 Muscle Position and Dry Needling Efficacy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07629141
Status Recruiting
Phase
Sponsor University of Alcala
Condition Neck Pain
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-06-08
Primary Completion 2026-09-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
All Conditions
Interventions
Dry needling technique with the shoulder in full adduction.Dry needling technique with the shoulder in 90° abduction.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-06-08 with a primary completion date of 2026-09-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Currently, no previous studies have investigated how the position of a muscle before dry needling may influence the outcome and effectiveness of the treatment. This study aims to demonstrate whether the position of the upper trapezius muscle during dry needling treatment influences the outcome of that treatment in subjects with neck pain. A total of 46 participants with chronic neck pain will be recruited and randomly assigned to two groups: a dry needling group with the muscle in a stretched position and a dry needling group with the muscle in a shortened position. A total of two treatment sessions will be performed, separated by a 7-day interval. The primary outcome measure will be the intensity of neck and head pain, measured using the visual analog scale (VAS). Other variables to be measured include the cervical disability index, kinesiophobia, and catastrophizing (using a self-completion questionnaire), as well as participants' expectations and post-needling pain.

Eligibility Criteria

Inclusion Criteria: * Age between 18 and 65 years * Neck pain lasting more than 3 months * Current neck pain greater than 3/10 on the VAS (Visual Analog Scale) * Presence of active trigger points in the upper trapezius muscle, meeting the following criteria: Painful point within a taut band whose palpation reproduces the patient's symptoms. Exclusion Criteria: * Neck pain with a medical diagnosis (fractures, arthritis, fibromyalgia, etc.) * Radicular pain (paresthesia, burning, electric shocks) * Whiplash or any recent trauma * Previous surgery * Treatment by another physiotherapist within the last 3 months * Infections * Needle phobia * Use of anticoagulant medications * Pregnancy * Fibromyalgia * Metal allergies * Cognitive deficits or communication problems

Contact & Investigator

Central Contact

Daniel Pecos-Martin, PhD

✉ daniel.pecos@uah.es

📞 34918855142

Frequently Asked Questions

Who can join the NCT07629141 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Neck Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07629141 currently recruiting?

Yes, NCT07629141 is actively recruiting participants. Contact the research team at daniel.pecos@uah.es for enrollment information.

Where is the NCT07629141 trial being conducted?

This trial is being conducted at Alcalá de Henares, Spain, Alcalá de Henares, Spain.

Who is sponsoring the NCT07629141 clinical trial?

NCT07629141 is sponsored by University of Alcala. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology